tiprankstipranks
Trending News
More News >
Noile-Immune Biotech Inc. (JP:4893)
:4893
Japanese Market

Noile-Immune Biotech Inc. (4893) Income Statement

Compare
0 Followers

Noile-Immune Biotech Inc. Income Statement

Last quarter (Q2 2025), Noile-Immune Biotech Inc.'s total revenue was ¥2.00M, an increase of Infinity% from the same quarter last year. In Q2, Noile-Immune Biotech Inc.'s net income was ¥-171.00M. See Noile-Immune Biotech Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 7.59M¥ 316.82M¥ 625.78M¥ 100.73M¥ 97.28M
Gross Profit
¥ 7.39M¥ 314.56M¥ 618.71M¥ 77.83M¥ 94.31M
Operating Expenses
¥ 1.08B¥ 1.09B¥ 725.05M¥ 845.34M¥ 698.78M
Depreciation and Amortization
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 12.81M
EBITDA
¥ -1.07B¥ -775.39M¥ -106.34M¥ -767.51M¥ -591.67M
Operating Income
¥ -1.07B¥ -775.39M¥ -106.34M¥ -767.51M¥ -604.48M
Other Income/Expenses
¥ 107.15M¥ -352.20M¥ -277.86M¥ -25.10M¥ -26.50M
Pretax Income
¥ -962.03M¥ -1.13B¥ -384.20M¥ -792.62M¥ -630.97M
Net Income
¥ -964.46M¥ -1.13B¥ -386.62M¥ -795.03M¥ -636.65M
Per Share Metrics
Basic EPS
¥ -22.26¥ -27.25¥ -9.87¥ -19.33¥ -15.48
Diluted EPS
¥ -22.26¥ -27.25¥ -9.87¥ -19.33¥ -14.52
Weighted Average Shares Outstanding
43.30M 41.47M 39.17M 41.12M 41.12M
Weighted Average Shares Outstanding (Diluted)
43.30M 41.47M 39.17M 41.12M 43.86M
Currency in JPY

Noile-Immune Biotech Inc. Earnings and Revenue History